Belgium· BE-AMP-SAM244894-00
Neohepatect 50 IU/ml
A hepatitis b immunoglobulin product containing human hepatitis b immunoglobulin, registered in Belgium by Biotest Pharma. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Human Hepatitis B Immunoglobulin
- Manufacturer
- Biotest Pharma
- Country
- Belgium (BE)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3153087
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hepatitis b immunoglobulin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayHepatectBiotest Pharma GmbH
- SwedenNeohepatect 50 IE/ml Infusionsvätska, lösningBiotest Pharma GmbH
- GermanyFoveptaBiotest Pharma Gmbh
- United StatesHepaGam BKamada Ltd.
- FinlandImmunogamCangene Europe Limited
- CzechiaZUTECTRABiotest Pharma GmbH, Dreieich
- IcelandZutectraBiotest Pharma GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Hepatect Cp, Uman Big
- Bulgaria · Хепатект Ср
- Czechia · Neohepatect
- Germany · Fovepta, Hepatect Cp
- Denmark · Hepatect Cp, Uman Big
- Spain · Hepatect, Igantibe
- Finland · Hepatect
- France · Immunoglobuline Humaine De L'hepatite B Lfb, Ivhebex
- United Kingdom (Northern Ireland) · Hepatect Cp, Human Hepatitis B Immunoglobulin Bio Products Laboratory
- Greece · Hepatect Cp, Venbig
- Croatia · Hepatect Cp, Venbig
- Hungary · Umanbig, Venbig
- Ireland · Hepatect Cp
- Iceland · Zutectra
- Italy · Igantibe, Immunohbs
- Liechtenstein · Zutectra
- Lithuania · Hepetra
- Netherlands · Hepatect Cp, Uman Big
- Norway · Hepatect, Umanbig
- Poland · Gamma Anty-Hbs 200, Hepatect Cp
- Portugal · Gammaglobulina Antihepatitis B P Behring, Hepatect Cp
- Romania · Hepatect Cp
- Sweden · Neohepatect, Umanbig
- Slovenia · Hepatect Cp
- Slovakia · Igantibe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d4f6e11-4f93-45ee-9961-6c5ab83fca50 GET /v1/drugs/5d4f6e11-4f93-45ee-9961-6c5ab83fca50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Neohepatect 50 IU/ml",
"name_fr": "Neohepatect 50 IU/ml",
"name_nl": "Neohepatect 50 IU/ml",
"amp_code": "SAM244894-00",
"strengths": [
"50.0000"
],
"pack_count": 1,
"substances": [
"Human Hepatitis B Immunoglobulin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Hepatitis B Immunoglobulin",
"authorisation_numbers": [
"BE244894"
]
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.